김태우 (고려대학교 의과대학)님 | 한빛사연구자 > 한빛사

The E2F1-HMGCR axis promotes ferroptosis resistance in immune refractory tumor cells

Nat. Commun., 03 December 2025;16,10849(2025) | https://doi.org/10.1038/s41467-025-66282-x

2025-12
의약학
한빛사논문

Cytoplasmic WEE1 promotes resistance to PD-1 blockade through hyperactivation of the HSP90A/TCL1/AKT signaling axis in NANOGhigh tumors

Cancer Immunol. Res., Mar 11 2025, | https://doi.org/10.1158/2326-6066.CIR-24-0379

2025-03
의약학
한빛사논문

TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway

Nat. Commun., 2023 May 10;14(1):2691 | https://doi.org/10.1038/s41467-023-38318-7

2023-05
의약학
한빛사논문

PD-L1 siRNA–hyaluronic acid conjugate for dual-targeted cancer immunotherapy

J. Control. Release, Volume 346, June 2022, Pages 226-239 | https://doi.org/10.1016/j.jconrel.2022.04.023

2022-06
의약학
한빛사논문

Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes

Nat. Commun., Published 19 April 2022 | https://doi.org/10.1038/s41467-022-29611-y

2022-04
의약학
한빛사논문

Targeting the NANOG/HDAC1 axis reverses resistance to PD-1 blockade by reinvigorating the antitumor immunity cycle

J. Clin. Invest., Volume 132, Issue 6 on March 15, 2022 | https://doi.org/10.1172/JCI147908

2022-03
의약학
한빛사논문

LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells

Autophagy, Posted online: 07 Aug 2020 | https://doi.org/10.1080/15548627.2020.1805214

2020-08
의약학
한빛사논문

HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors

Nat. Commun., Published 28 January 2020, 11, Article number: 562 | DOI https://doi.org/10.1038/s41467-019-14259-y

2020-01
의약학
한빛사논문

Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance

J. Clin. Invest., Published August 20, 2018 | https://doi.org/10.1172/JCI96804

2018-08
의약학
한빛사논문

Nanog signaling in cancer promotes stem-like phenotype and immune evasion

J. Clin. Invest., 2012;122(11):4077–4093. | doi:10.1172/JCI64057

2012-10
의약학
한빛사논문, 상위피인용논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기